SCHEMBL8285332

SCHEMBL8285332

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2cc(OCC3CC3)ncc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
PDE11A Q9HCR9 1/20 0.34
GSK3B P49841 4/20 0.33
PIK3CA P42336 1/20 0.33
PRKDC P78527 1/20 0.33
BUB1 O43683 5/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
CCND2 P30279 1/20 0.33
CCND3 P30281 1/20 0.33
CDK2 P24941 1/20 0.33
LRRK2 Q5S007 2/20 0.32
BRD4 O60885 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPK1 P28482 1/20 0.32
ROCK2 O75116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287581 0.85 GABRG2 (0.33) GABRG2GABRB3GABRA5PDE11AGSK3B
SCHEMBL8285261 0.85 GSK3B (0.38) GABRG2GABRB3GABRA5PDE11AGSK3B
SCHEMBL8287459 0.84 GABRP (0.38) GABRG2GABRB3GABRA5PDE11AGSK3B
SCHEMBL8287240 0.83 HTT (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287576 0.83 GSK3B (0.39) PDE11AGSK3BPIK3CAPRKDCCDK4
SCHEMBL8285333 0.82 GSK3B (0.36) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285316 0.82 PDE11A (0.40) PDE11AGSK3BPIK3CABUB1CDK4
SCHEMBL8285335 0.82 MAT2A (0.37) PDE11AGSK3BBUB1CDK4CCND1
SCHEMBL8287490 0.82 CDK4 (0.38) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285329 0.81 GSK3B (0.40) PDE11AGSK3BPIK3CAPRKDCCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed